Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SHRA-1904 by Jiangsu Hengrui Medicine for Solid Tumor: Likelihood of Approval
SHRA-1904 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Solid Tumor. According to GlobalData,...
SHRA-1904 by Jiangsu Hengrui Medicine for Pancreatic Cancer: Likelihood of Approval
SHRA-1904 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Pancreatic Cancer. According to GlobalData,...
SHRA-1904 by Jiangsu Hengrui Medicine for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
SHRA-1904 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According...
SHRA-1904 by Jiangsu Hengrui Medicine for Gastric Cancer: Likelihood of Approval
SHRA-1904 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Gastric Cancer. According to GlobalData,...